BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

886 related articles for article (PubMed ID: 32546613)

  • 1. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
    Cassard H; Huor A; Espinosa JC; Douet JY; Lugan S; Aron N; Vilette D; Delisle MB; Marín-Moreno A; Peran P; Beringue V; Torres JM; Ironside JW; Andreoletti O
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
    Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease.
    Gelpi E; Baiardi S; Nos C; Dellavalle S; Aldecoa I; Ruiz-Garcia R; Ispierto L; Escudero D; Casado V; Barranco E; Boltes A; Molina-Porcel L; Bargalló N; Rossi M; Mammana A; Tiple D; Vaianella L; Stoegmann E; Simonitsch-Klupp I; Kasprian G; Klotz S; Höftberger R; Budka H; Kovacs GG; Ferrer I; Capellari S; Sanchez-Valle R; Parchi P
    Acta Neuropathol Commun; 2022 Aug; 10(1):114. PubMed ID: 35978418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
    Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
    Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification.
    Takeuchi A; Kobayashi A; Parchi P; Yamada M; Morita M; Uno S; Kitamoto T
    Lab Invest; 2016 May; 96(5):581-7. PubMed ID: 26878132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond PrP9res) type 1/type 2 dichotomy in Creutzfeldt-Jakob disease.
    Uro-Coste E; Cassard H; Simon S; Lugan S; Bilheude JM; Perret-Liaudet A; Ironside JW; Haik S; Basset-Leobon C; Lacroux C; Peoch' K; Streichenberger N; Langeveld J; Head MW; Grassi J; Hauw JJ; Schelcher F; Delisle MB; Andréoletti O
    PLoS Pathog; 2008 Mar; 4(3):e1000029. PubMed ID: 18389084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-occurrence of types 1 and 2 PrP(res) in sporadic Creutzfeldt-Jakob disease MM1.
    Kobayashi A; Mizukoshi K; Iwasaki Y; Miyata H; Yoshida Y; Kitamoto T
    Am J Pathol; 2011 Mar; 178(3):1309-15. PubMed ID: 21356381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A traceback phenomenon can reveal the origin of prion infection.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Creutzfeldt-Jakob disease prion propagation by the A224V mutation.
    Watts JC; Giles K; Serban A; Patel S; Oehler A; Bhardwaj S; Guan S; Greicius MD; Miller BL; DeArmond SJ; Geschwind MD; Prusiner SB
    Ann Neurol; 2015 Oct; 78(4):540-53. PubMed ID: 26094969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive protein misfolding cyclic amplification of sporadic Creutzfeldt-Jakob disease prions is strongly seed and substrate dependent.
    Bélondrade M; Nicot S; Mayran C; Bruyere-Ostells L; Almela F; Di Bari MA; Levavasseur E; Watts JC; Fournier-Wirth C; Lehmann S; Haïk S; Nonno R; Bougard D
    Sci Rep; 2021 Feb; 11(1):4058. PubMed ID: 33603091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.
    Parchi P; Cescatti M; Notari S; Schulz-Schaeffer WJ; Capellari S; Giese A; Zou WQ; Kretzschmar H; Ghetti B; Brown P
    Brain; 2010 Oct; 133(10):3030-42. PubMed ID: 20823086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties.
    Bishop MT; Will RG; Manson JC
    Proc Natl Acad Sci U S A; 2010 Jun; 107(26):12005-10. PubMed ID: 20547859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions.
    Chapuis J; Moudjou M; Reine F; Herzog L; Jaumain E; Chapuis C; Quadrio I; Boulliat J; Perret-Liaudet A; Dron M; Laude H; Rezaei H; Béringue V
    Acta Neuropathol Commun; 2016 Feb; 4():10. PubMed ID: 26847207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI characteristics of sporadic CJD with valine homozygosity at codon 129 of the prion protein gene and PrPSc type 2 in Japan.
    Fukushima R; Shiga Y; Nakamura M; Fujimori J; Kitamoto T; Yoshida Y
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):485-7. PubMed ID: 14966171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease creates a new prion strain.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    J Biol Chem; 2007 Oct; 282(41):30022-8. PubMed ID: 17709374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?
    Kobayashi A; Parchi P; Yamada M; Brown P; Saverioni D; Matsuura Y; Takeuchi A; Mohri S; Kitamoto T
    J Virol; 2015 Apr; 89(7):3939-46. PubMed ID: 25609817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creutzfeldt-Jakob disease.
    Sikorska B; Knight R; Ironside JW; Liberski PP
    Adv Exp Med Biol; 2012; 724():76-90. PubMed ID: 22411235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic diversity of genetic Creutzfeldt-Jakob disease: a histo-molecular-based classification.
    Baiardi S; Rossi M; Mammana A; Appleby BS; Barria MA; Calì I; Gambetti P; Gelpi E; Giese A; Ghetti B; Herms J; Ladogana A; Mikol J; Pal S; Ritchie DL; Ruf V; Windl O; Capellari S; Parchi P
    Acta Neuropathol; 2021 Oct; 142(4):707-728. PubMed ID: 34324063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond PrP res type 1/type 2 dichotomy in Creutzfeldt-Jakob disease.
    Uro-Coste E; Cassard H; Simon S; Lugan S; Bilheude JM; Perret-Liaudet A; Ironside JW; Haik S; Basset-Leobon C; Lacroux C; Peoch K; Streichenberger N; Langeveld J; Head MW; Grassi J; Hauw JJ; Schelcher F; Delisle MB; Andréoletti O
    PLoS Pathog; 2008 Mar; 4(3):e1000029. PubMed ID: 18383623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sporadic Creutzfeldt-Jakob Disease MM1+2C and MM1 are Identical in Transmission Properties.
    Kobayashi A; Matsuura Y; Iwaki T; Iwasaki Y; Yoshida M; Takahashi H; Murayama S; Takao M; Kato S; Yamada M; Mohri S; Kitamoto T
    Brain Pathol; 2016 Jan; 26(1):95-101. PubMed ID: 25851836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.